Fatal Cerebral Infarction After Nasal Augmentation With Hyaluronic Acid

Fatal Cerebral Infarction and Ophthalmic Artery Occlusion After Nasal Augmentation With Hyaluronic Acid - A Case Report and Review

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04189068

Enrollment

Registered

2019-12-06

Start date

2019-09-24

Completion date

2019-10-22

Last updated

2019-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Magnetic Resonance Angiography

Keywords

Cerebral Infarction Hyaluronic Acid Embolism

Brief summary

this study discussed the pathogenesis, treatment, and prognosis of severe cerebral infarction and ophthalmic artery occlusion for Aisan induced by hyalruonic acid filler injection.

Detailed description

Intra-arterial thrombolysis and retrobulbar injection of hyaluronidase have been used for HA-induced ophthalmic artery obstruction.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of cerebral infarction

Exclusion criteria

* fat embolism

Design outcomes

Primary

Measure	Time frame	Description
pulse	0-6 day	Monitore the beats per minute over the past 6 days.
blood pressure	0-6 day	Monitor the blood pressure and record with mm Hg over the past 6 days.

Countries

China

Outcome results